Porvair Sciences Has Announced MicroBurst™
September 16, 2010
Eliminating the Difficulties In Handling Adhesive Sealing Films A revolutionary new microencapsulated clear sealing film for microplates. Using adhesive seals whilst wearing laboratory gloves can often prove to be difficult. The glued surface of the seal can easily stick to your glove rather than your microplate. Porvair MicroBurst sealing films have been developed to eliminate [...]
September 16, 2010
Enhanced specificity, affinity and reproducibility Naarden, The Netherlands – BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect® HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant [...]
Krome Orange from Beckman Coulter Heightens Sensitivity in Multi-color Flow Cytometry
September 16, 2010
New Dye’s Emission Spectrum Closely Resembles Pacific Orange BREA, Calif. - Beckman Coulter, Inc. introduces Krome Orange, a novel violet-excited organic dye that expands the range of available choices and dye sensitivity limits for violet lasers. Common gating markers can be easily transferred to this fluorochrome, freeing other channels for use with more esoteric markers [...]
GenomeQuest Appoints Richard Resnick as Acting CEO
September 16, 2010
Westborough, MA - GenomeQuest, Inc. today announced the appointment of Richard Resnick as Acting CEO of the company. He succeeds former CEO Ron Ranauro, who has resigned. During this transition, Resnick will retain his role as vice president of products and services at GenomeQuest. “I want to thank Ron for his strong contributions over the [...]
Pall Corporation’s New GeneDisc® Rapid Microbiology System Advances Quality Assurance Analysis
September 16, 2010
Dramatic Time Savings for Biopharma Manufacturing Using Novel qPCR Technology PORT WASHINGTON, N.Y. - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the introduction of the GeneDisc® Rapid Microbiology System for advanced microbial quality monitoring. This system represents Pall’s latest quality assurance innovation for the pharmaceutical manufacturing industry. “The [...]
Research Team from Fred Hutchinson Cancer Center Wins 2010 BioFlux Innovation Award
September 16, 2010
Group will use BioFlux System for advanced screening applications applicable to women’s reproductive health South San Francisco, California, September 16, 2010 – Fluxion Biosciences, Inc. announced today that a research team from Fred Hutchinson Cancer Center has won the 2010 BioFlux Innovation Award competition. Laura Sycuro, Ph.D., a post-doctoral research fellow in the lab of [...]
Bioo Scientific Launched Color Endpoint Assays for In Vivo AST and LDH Analysis
September 16, 2010
Today Bioo Scientific launched the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays for in vivo toxicity analysis. Austin, TX - Bioo Scientific announced the availability of the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays which use a proprietary, innovative technology for visible detection of in vivo toxicity [...]
September 15, 2010
Washington, D.C. and London, UK – Diaceutics Limited (www.diaceutics.com) and London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, today announce a strategic partnership to develop software decision tools that will provide biopharmaceutical companies with rapid and extensive access to the world’s leading academic biomarker research groups. The [...]
September 15, 2010
East Norwalk, CT - Seven weeks of on-site tests were recently completed at a major pipeline company in the Southwest to determine the effectiveness of the Wilks InfraSpec VFA-IR Spectrometer, Model EB, for detecting biodiesel contamination in diesel fuels about to enter the pipeline. Over 20 different diesel fuels were tested for the presence of [...]
September 15, 2010
Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts SAN DIEGO - Researchers from Illumina, Inc. (NASDAQ:ILMN) and the Wellcome Trust Sanger Institute have used Illumina's next generation sequencing technology to create a draft genome sequence for the endangered Tasmanian devil, and will use this to find genetic mutations in the transmissible cancer [...]
